Valuation: InterCure Ltd.

Market Cap 156M 46.27B 134M 126M 115M 216M 14.88B 219M 1.48B 579M 7.46B 584M 572M 24.82B P/E 2024
-4.01x
P/E 2025 -4.87x
Enterprise Value 292M 86.79B 252M 237M 216M 405M 27.91B 411M 2.78B 1.09B 13.99B 1.1B 1.07B 46.55B EV / Sales 2024
1.69x
EV / Sales 2025 1.16x
Free-Float
60.83%
Yield 2024 *
-
Yield 2025 -
1 day+1.10%
1 week-3.79%
Current month-9.62%
1 month-0.21%
3 months+17.55%
6 months+1.86%
Current year-12.02%
1 week 279.4
Extreme 279.4
294.2
1 month 274
Extreme 274
315
Current year 225.3
Extreme 225.3
359
1 year 225.3
Extreme 225.3
574
3 years 225.3
Extreme 225.3
1,346
5 years 225.3
Extreme 225.3
2,635
10 years 146.83
Extreme 146.8255
6,317.95
Manager TitleAgeSince
Chief Executive Officer 55 23/12/2019
Director of Finance/CFO 47 29/02/2020
General Counsel - 31/03/2022
Director TitleAgeSince
Director/Board Member 50 02/09/2015
Director/Board Member 66 13/12/2014
Chairman 55 12/02/2025
Date Insider Type Main position Quantity % Market Cap.
18/03/26 Other

Director

15,000 0.0274%
09/11/22 Option

Chief Financial Officer

230,000 0.5066%
09/11/22 Option 230,000 0.5066%
Change 5-day change 1-year change 3-year change Capi.($)
+1.10%-3.79%-48.41%-50.53% 52.1M
+1.98%+24.04%+0.39%+214.52% 309M
+1.18%+24.82%-14.93%-12.76% 171M
+0.51%+3.65%+4.19%+85.98% 141M
+2.38%+6.17%-34.85%-27.12% 85.25M
Average +1.43%+9.40%-18.72%+42.02% 151.82M
Weighted average by Cap. +1.51%+14.76%-9.67%+94.00%

Financials

2024 2025
Net sales 239M 70.98B 206M 194M 176M 331M 22.83B 336M 2.27B 889M 11.44B 897M 877M 38.07B 270M 80.3B 233M 219M 200M 375M 25.83B 380M 2.57B 1.01B 12.94B 1.01B 992M 43.07B
Net income -67.8M -20.15B -58.56M -54.98M -50.06M -94.05M -6.48B -95.42M -645M -252M -3.25B -255M -249M -10.81B -35.71M -10.61B -30.84M -28.96M -26.37M -49.54M -3.41B -50.26M -340M -133M -1.71B -134M -131M -5.69B
Net Debt 133M 39.45B 115M 108M 98.02M 184M 12.69B 187M 1.26B 494M 6.36B 498M 488M 21.16B 136M 40.52B 118M 111M 101M 189M 13.03B 192M 1.3B 507M 6.53B 512M 501M 21.73B
Logo InterCure Ltd.
InterCure Ltd. is an Israel-based company engaged in the medical cannabis industry. Through its wholly owned subsidiary, Canndoc Ltd., the Company cultivates, produces, processes, markets, and distributes medical cannabis products. Its operations include the development and manufacture of pharmaceutical-grade medical cannabis products produced in accordance with Good Manufacturing Practice (GMP) standards. The Company offers a range of cannabis-based products for medical use and operates across various stages of the medical cannabis value chain, including cultivation, manufacturing, logistics, distribution, and retail activities. In addition, the Company is involved in the import, export, and commercialization of medical cannabis products and related healthcare solutions in Israel and selected international markets.
Employees
285
Date Price Change Volume
17/08/26 ILA 284.70 +1.10% 27,204
14/08/26 ILA 281.60 -2.63% 9,776
13/08/26 ILA 289.20 +2.48% 18,912
12/08/26 ILA 282.20 -0.95% 22,975
11/08/26 ILA 284.90 -2.56% 23,806
  1. Stock Market
  2. Stocks
  3. INCR Stock